Registration - Amendment

POLICY IMPACT COMMUNICATIONS, INC. for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY

Firm
Client
Income
—
Expenses
—

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medical, pharmaceutical, and tax issues.

LobbyistCovered position, as disclosed
JOHN M HADDOW New —
JOHN DREW HIATT New —
WILLIAM NIXON New —

Medicare/Medicaid MMM

Medical, pharmaceutical, and tax issues.

LobbyistCovered position, as disclosed
JOHN M HADDOW New —
JOHN DREW HIATT New —
WILLIAM NIXON New —

Consumer Issues/Safety/Products CSP

Medical, pharmaceutical, and tax issues.

LobbyistCovered position, as disclosed
JOHN M HADDOW New —
JOHN DREW HIATT New —
WILLIAM NIXON New —

Pharmacy PHA

Medical, pharmaceutical, and tax issues.

LobbyistCovered position, as disclosed
JOHN M HADDOW New —
JOHN DREW HIATT New —
WILLIAM NIXON New —

Medical/Disease Research/Clinical Labs MED

Medical, pharmaceutical, and tax issues.

LobbyistCovered position, as disclosed
JOHN M HADDOW New —
JOHN DREW HIATT New —
WILLIAM NIXON New —

Taxation/Internal Revenue Code TAX

Medical, pharmaceutical, and tax issues.

LobbyistCovered position, as disclosed
JOHN M HADDOW New —
JOHN DREW HIATT New —
WILLIAM NIXON New —

Manufacturing MAN

Medical, pharmaceutical, and tax issues.

LobbyistCovered position, as disclosed
JOHN M HADDOW New —
JOHN DREW HIATT New —
WILLIAM NIXON New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
TAKEDA PHARMACEUTICAL COMPANY LIMITED United States United States 100.0% $25,500

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.